You may also like
Terumo Signs Consent Decree with the FDA (Press Release)
During an inspection last year at Terumo Cardiovascular Systems Ann Arbor, Mich., plant, FDA officials found numerous violations to good manufacturing practice and medical device reporting requirements. On March 17, Terumo executive officers signed a consent decree of permanent injunction and under its terms, Terumo will pay almost $35 million in profits from past sales to the federal government.
2 min read
Economics of Blood Management (EP Video)
Karim Jabr discusses the economic impact of blood management in cardiac surgery (19:12 minutes).
1 min read
Platelet-Rich Plasma Suppresses Osteoclastogenesis by Promoting the Secretion of Osteoprotegerin
aim of the present study was to evaluate the effects of platelet-rich plasma and platelet-poor plasma on osteoclastogenesis with rat bone marrow cell culture.
1 min read